London-based digital health startup Lumeon lands $30 million in Series D funding to accelerate growth in the U.S.
Lumeon, a London, England-based digital health startup company providing care pathway management solutions to the healthcare industry, today announced that it has closed $30M in Series D funding led by new investors Optum Ventures and Endeavour Vision, with participation from current investors LSP, MTIP, IPF Partners, Gilde and Amadeus Capital Partners.
Lumeon will use the new capital infusion to extend the reach of its Care Pathway Management (CPM) platform, which helps healthcare providers automate their patient care coordination to improve care quality, deliver better outcomes and reduce costs.
Founded in 2005 by Robbie Hughes, Lumeon helps health systems take control of their care delivery processes by orchestrating and automating care journeys to operate with predictability and efficiency. From scheduling and revenue management to clinical reporting and aftercare, by looking across the end-to end care pathway, Lumeon addresses the system, and not just the symptom, behind healthcare transformation.
Lumeon’s customers number among Europe’s fastest growing and most innovative healthcare providers including BUPA, Nuffield Health, Alliance Medical, HCA, Optegra and Newmedica. It is headquartered in London employing over 90 people.
Lumeon’s CPM platform uses real-time data to dynamically guide patients and care teams along their care journeys. By automating, orchestrating and virtualizing care delivery across care settings, Lumeon’s solutions allow health systems to operate with predictability and efficiency, delivering optimal care to each patient while substantially lowering costs for healthcare providers.
“While the markets for data analytics, clinical decision support and patient engagement are well established, what is missing today is the ability to effectively connect them to solve the problem of personalizing care delivery in a scalable way,” said Lumeon founder and CEO Robbie Hughes. “The ‘last mile’ that turns the insight into action is the hardest part for health systems, and is the core of the Lumeon proposition.”
Hughes continued, “This investment will allow us to continue on our rapid growth path, as we help healthcare systems develop and scale new models of delivery.”
“As the technology-driven transformation of healthcare is accelerated by COVID-19, Lumeon’s ability to optimize the care of every patient based on individual risk, cost, engagement and social determinants is crucial for their customers to operate effectively,” said Optum Ventures Principal Dr. Ashish Patel. “We believe Lumeon is uniquely positioned to help health systems unlock new opportunities in sustainable, profitable care delivery.”
Lumeon’s CPM platform integrates with all electronic health record (EHR) systems in addition to incorporating required clinical and administrative data from point solutions and devices, addressing the fragmented nature of healthcare technology and the challenge of interoperability. By extending beyond the confines of a healthcare provider’s EHR, Lumeon’s configurable solutions maximize current investments as organizations evolve their care delivery models.
“Lumeon’s flexible CPM platform offers an unparalleled solution to the care pathway challenges many health systems face,” said Alexander Schmitz, Partner at Endeavour Vision. “By coordinating processes across the continuum – from basic administrative tasks to highly complex clinical optimization protocols – Lumeon is helping to define a new future for patient care.”